QS Investors’s Ionis Pharmaceuticals IONS Stock Holding History

QS Investors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,400	Closed	-$142K	–	1354
2020 Q2	$142K	Sell	2,400 -1,600	-40%	-$89K	﹤0.01%	1220
2020 Q1	$190K	Hold	4,000	–	–	﹤0.01%	1088
2019 Q4	$244K	Hold	4,000	–	–	﹤0.01%	1141
2019 Q3	$240K	Hold	4,000	–	–	﹤0.01%	1155
2019 Q2	$258K	Hold	4,000	–	–	﹤0.01%	1145
2019 Q1	$325K	Sell	4,000 -10	-0.2%	-$645	﹤0.01%	1104
2018 Q4	$217K	Hold	4,010	–	–	﹤0.01%	1104
2018 Q3	$207K	Hold	4,010	–	–	﹤0.01%	1196
2018 Q2	$167K	Hold	4,010	–	–	﹤0.01%	1263
2018 Q1	$177K	Hold	4,010	–	–	﹤0.01%	1217
2017 Q4	$202K	Hold	4,010	–	–	﹤0.01%	1206
2017 Q3	$203K	Hold	4,010	–	–	﹤0.01%	1217
2017 Q2	$204K	Hold	4,010	–	–	﹤0.01%	1203
2017 Q1	$161K	Buy	4,010 +4,000	+40,000%	+$180K	﹤0.01%	1299
2016 Q4	$1K	Hold	10	–	–	﹤0.01%	1631
2016 Q3	$1K	Sell	10 -4,187	-100%	-$131K	﹤0.01%	1615
2016 Q2	$98K	Buy	+4,197	New	+$135K	﹤0.01%	1268
2015 Q4	–	Sell	-91,753	Closed	-$3.71M	–	2081
2015 Q3	$3.71M	Sell	91,753 -6,225	-6%	-$322K	0.04%	462
2015 Q2	$5.64M	Sell	97,978 -19,247	-16%	-$1.22M	0.07%	343
2015 Q1	$7.46M	Sell	117,225 -13,855	-11%	-$940K	0.08%	266
2014 Q4	$8.09M	Buy	+131,080	New	+$6.47M	0.09%	248

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

QS Investors's IONS Position: Q3 2020 in Review

QS Investors sold out of Ionis Pharmaceuticals (IONS) in Q3 2020, closing a stake of 2,400 shares — an estimated $142K sold.

QS Investors first reported a position in IONS in Q4 2014 and held it in 21 quarters. The position peaked at $8.09M in Q4 2014. 367 funds tracked by Wall St. Rank hold IONS as of Q3 2020.

QS Investors reported no remaining Ionis Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
QS Investors sold 2,400 Ionis Pharmaceuticals shares in Q3 2020, an estimated $142K.
QS Investors first reported a position in Ionis Pharmaceuticals in Q4 2014 and held it in 21 quarters.
QS Investors's Ionis Pharmaceuticals position peaked at $8.09M in Q4 2014.
367 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.